Similasan Husten mit Verschleimung
Similasan Husten mit Verschleimung is a medicine authorised by Swissmedic under authorisation number 66517. The authorisation holder is Similasan AG. The medicinal product code is Homeopathic medicines and the dispensing category is D: Supplied in pharmacies and drugstores after specialist advice, without a prescription. First authorisation was granted on 29 May 2018 and the authorisation is valid without a time limit. The export lists no ATC code for this medicine.
| Authorisation number | 66517 |
|---|---|
| Name | Similasan Husten mit Verschleimung |
| Full name | Similasan Husten mit Verschleimung, Sirup |
| Authorisation holder | Similasan AG |
| Medicinal product code | Homeopathic medicines |
| Dispensing category | D · No prescription, with advice |
| ATC code | not stated |
| First authorisation | 29 May 2018 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Similasan Husten mit Verschleimung, Sirup | D | 29 May 2018 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 2 | 118 | ml | - | 20.01.1. | D |
Scroll the table sideways
Other medicines from this authorisation holder
Frequently asked questions
Is Similasan Husten mit Verschleimung authorised in Switzerland?
Yes. Similasan Husten mit Verschleimung is authorised by Swissmedic under authorisation number 66517, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Similasan Husten mit Verschleimung have?
Similasan Husten mit Verschleimung is in dispensing category D. Supplied in pharmacies and drugstores after specialist advice, without a prescription.
Who is the authorisation holder of Similasan Husten mit Verschleimung?
The authorisation holder is Similasan AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.